Skip to main content
Clinical Trials/NCT04698876
NCT04698876CompletedNot Applicable

SALUS - Selbsttonometrie Und Datentransfer Bei Glaukompatienten Zur Verbesserung Der Versorgungssituation

University Hospital Muenster5 sites in 1 country267 target enrollmentStarted: February 11, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
267
Locations
5
Primary Endpoint
Number of observed pressure peaks (>30% of the patient-specific target pressure)

Study Overview

Brief Summary

The SALUS project is developing a new form of care, the application of self-tonometry by the patient itself, and an accompanying electronic case file connecting clinics, doctor's offices and patients.

Detailed Description

The SALUS project is developing an outpatient, intersectoral form of care in which patients measure their intraocular pressure in their home environment with a so-called self-tonometer. The measured intraocular pressure values are incorporated into daily pressure profiles, which can be viewed via an electronic case file together with further examination data both by the treating ophthalmologists in the doctor's offices and clinics and by the patients. The new form of care not only supports the telemedical networking of doctors but also increases the compliance by involving the patient in the entire course of the illness.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Requirement of a stationary day and night measurement
  • Statutory health insurance
  • Verified and suspicion of glaucoma diagnosis with suspicion of pressure variations and peaks or not attained target pressure or suspicion of glaucoma progression (H40.1, H40.2 und H42.-)
  • Willingness for therapy in one of the participating clinics
  • Adequate German language skills
  • Signed and dated informed consent for study participation and data transfer
  • Legal capacity of the insurant to agree to the study participation

Exclusion Criteria

  • Patients outside the catchment area of the participating clinics
  • Covering illnesses in psychiatry, neurology or other indications (e.g. impairment of independence) which make self-tonometry impossible
  • Strong communication barriers that do not allow the instruction to carry out the intervention
  • Unclear legal capacity of the potential study participants

Outcomes

Primary Outcomes

Number of observed pressure peaks (>30% of the patient-specific target pressure)

Time Frame: 7 days (outpatient) or minimum 24 hours (stationary)

Measurement of intraocular pressure by means of ICareHOME, rebound tonometry or Goldmann applanation tonometry.

Secondary Outcomes

  • Visual field index (VFI)(Baseline and after 9 and 12 months)
  • Quality of life (patient-oriented)(Baseline and after 12 months)
  • Number of sick pay days(12 month course)
  • Pattern standard deviation (PSD)(Baseline and after 9 and 12 months)
  • Rim volume(Baseline and after 12 months)
  • Rim area(Baseline and after 12 months)
  • Mean deviation (MD)(Baseline and after 9 and 12 months)
  • Retinal nerve fiber layer thickness(Baseline and after 12 months)
  • Number of inpatient and outpatient health services(12 month course)
  • Costs of health services(12 month course)
  • Number of periods of incapacity for work (unspecific and diagnosis-specific)(12 month course)
  • Systolic and diastolic blood pressure(for 24 hours during outpatient and stationary measurements of intraocular pressure)

Investigators

Sponsor
University Hospital Muenster
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nicole Eter

Chairholder and Head of the Department of Ophthalmology

University Hospital Muenster

Study Sites (5)

Loading locations...

Similar Trials